加拿大安大略省首次实体器官移植后角质形成细胞癌的发病率和危险因素
中位随访至2013年,16.6%的患者在中位3.96年后诊断为KC,发病率显著高于一般人群(标化发病比6.61)。移植时年龄较大、白人种族、移植前有皮肤癌史或移植后癌前病变是KC的独立危险因素。
要点
- 移植后KC发病率显著高于一般人群(标化发病比6.61)。
- 移植前有皮肤癌史者10年累积发病率达66.5%。
- 移植时年龄>65岁、白人种族、癌前病变是强危险因素。
核心结论
- 实体器官移植后角质形成细胞癌发病率显著增加,尤其在移植时年龄较大、白人种族及有皮肤癌或癌前病变史的患者中。
主要发现
- 中位年龄51岁(IQR 41-59),男性6608例(64.8%),白人5964例(58.5%)。
- 1690例(16.6%)诊断移植后KC,中位时间3.96年(IQR 1.94-7.09),发病率为2.63/100患者年(95%CI 2.51-2.76)。
- 标化发病比为6.61(95%CI 6.31-6.93)。
- 10年累积发病率:移植前有皮肤癌史者66.5%,移植时年龄51-65岁者27.5%,>65岁者40.5%,白人24.1%。
- 独立危险因素:移植时年龄>65岁 vs 18-35岁 aHR 9.27(95%CI 7.08-12.14);白人 vs 黑人 aHR 8.50(95%CI 4.03-17.91);移植前侵袭性皮肤癌 aHR 4.30(95%CI 3.72-4.98);移植后癌前皮肤病变 aHR 4.32(95%CI 3.77-4.95)。
临床怎么用
- 对移植时年龄较大、白人种族、有皮肤癌或癌前病变史的高危患者,应考虑加强皮肤癌筛查、教育和早期化学预防干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Keratinocyte carcinoma (KC), also known as nonmelanoma skin cancer, is the most common malignancy after solid organ transplant. Epidemiologic data on posttransplant KC in North America are limited by a lack of KC capture in cancer and transplant registries. OBJECTIVE: To estimate the incidence and identify risk factors for posttransplant KC. DESIGN, SETTING, AND PARTICIPANTS: This population-based inception cohort study in Ontario, Canada, used linked administrative databases and a health insurance claims-based algorithm. Participants were adult recipients of a first kidney, liver, heart, or lung transplant from January 1, 1994, to December 31, 2012. The cohort (n = 10 198) was followed up to December 31, 2013. Data were analyzed from May 31, 2016, to April 21, 2017. EXPOSURES: Solid organ transplant with functioning graft. MAIN OUTCOMES AND MEASURES: Age- and sex-adjusted standardized incidence ratio for KC in the transplant cohort was compared with that in the general population. Cumulative incidence of posttransplant KC was estimated using cumulative incidence functions, accounting for the competing risks of death or kidney graft loss. The association between KC and patient-, transplant-, and health services-related factors was evaluated with a multivariable cause-specific hazards model. RESULTS: A total of 10 198 transplant recipients were included in the study. The median (interquartile range [IQR]) age at transplant was 51 (41-59) years, with most recipients being male (6608 [64.8%]) and white (5964 [58.5%]). Posttransplant KC was diagnosed in 1690 patients (16.6%) after a median (IQR) of 3.96 (1.94-7.09) years, with an incidence rate of 2.63 per 100 patient-years (95% CI, 2.51-2.76). The rate of KC was significantly higher after transplant compared with the general population (standardized incidence ratio, 6.61; 95% CI, 6.31-6.93). The highest 10-year cumulative incidence was in the subsets of patients with a history of pretransplant skin cancer (66.5%), older than 50 years at transplant (27.5% for 51-65 years; 40.5% for >65 years), and of the white race (24.1%). The strongest independent risk factors for KC included older age at transplant (adjusted hazard ratio [aHR], 9.27; 95% CI, 7.08-12.14 for >65 years vs 18-35 years), white vs black race (aHR, 8.50; 95% CI, 4.03-17.91), pretransplant invasive skin cancer (aHR, 4.30; 95% CI, 3.72-4.98), and posttransplant precancerous skin lesions (aHR, 4.32; 95% CI, 3.77-4.95). CONCLUSIONS AND RELEVANCE: The incidence of KC appeared to be substantially increased after transplant, particularly in patients who were older at transplant, were white, and had a history of cancerous or precancerous skin tumors; intensified skin cancer screening, education, and early use of chemopreventive interventions may be warranted for these high-risk patient subsets.
引用
- Park CK, Fung K, Austin PC, et al. Incidence and Risk Factors of Keratinocyte Carcinoma After First Solid Organ Transplant in Ontario, Canada. JAMA Dermatol. 2019. PMID: 31116351. doi:10.1001/jamadermatol.2019.0692
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。